NVAX
Novavax, Inc.
NASDAQ · Healthcare · Biotechnology · US
$10.22
−1.16%0
Insider buys (3m)
0
Insider sells (3m)
$0.00
Net value (3m)
+7.8%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Jun 23, 2026 | Shiver John W. · director | A-Award | 14,180 | $0.00 |
| Jun 23, 2026 | Rodgers Richard J · director | A-Award | 14,180 | $0.00 |
| Jun 23, 2026 | MCGLYNN MARGARET G · director | A-Award | 21,270 | $9.13 |
| Jun 23, 2026 | MCGLYNN MARGARET G · director | A-Award | 14,180 | $0.00 |
| Jun 23, 2026 | Newton Charles W. · director | A-Award | 14,180 | $0.00 |
| Jun 23, 2026 | Shiver John W. · director | A-Award | 21,270 | $9.13 |
| Jun 23, 2026 | MOTT DAVID M · director | A-Award | 21,270 | $9.13 |
| Jun 23, 2026 | MOTT DAVID M · director | A-Award | 14,180 | $0.00 |
| Jun 23, 2026 | DOUGLAS RICHARD · director | M-Exempt | 18,880 | $0.00 |
| Jun 23, 2026 | King Rachel K. · director | M-Exempt | 18,880 | $0.00 |
| Jun 23, 2026 | MCGLYNN MARGARET G · director | M-Exempt | 18,880 | $0.00 |
| Jun 23, 2026 | King Rachel K. · director | A-Award | 21,270 | $9.13 |
| Jun 23, 2026 | King Rachel K. · director | A-Award | 14,180 | $0.00 |
| Jun 23, 2026 | DOUGLAS RICHARD · director | A-Award | 21,270 | $9.13 |
| Jun 23, 2026 | Rodgers Richard J · director | M-Exempt | 18,880 | $0.00 |
| Jun 23, 2026 | Rodgers Richard J · director | A-Award | 21,270 | $9.13 |
| Jun 23, 2026 | Alton Gregg H · director | M-Exempt | 18,880 | $0.00 |
| Jun 23, 2026 | Newton Charles W. · director | A-Award | 21,270 | $9.13 |
| Jun 23, 2026 | Alton Gregg H · director | A-Award | 21,270 | $9.13 |
| Jun 23, 2026 | Alton Gregg H · director | A-Award | 14,180 | $0.00 |
| Jun 23, 2026 | MOTT DAVID M · director | M-Exempt | 18,880 | $0.00 |
| Jun 23, 2026 | DOUGLAS RICHARD · director | A-Award | 14,180 | $0.00 |
| Apr 28, 2026 | Newton Charles W. · director | M-Exempt | 9,520 | $0.00 |
| Apr 16, 2026 | Walker Robert Edward · officer: EVP, R&D | A-Award | 99,500 | $8.46 |
| Apr 16, 2026 | Walker Robert Edward · officer: EVP, R&D | A-Award | 66,000 | $0.00 |
| Mar 12, 2026 | Shiver John W. · director | M-Exempt | 7,947 | $0.00 |
| Mar 9, 2026 | Kelly James Patrick · officer: EVP, CFO and Treasurer | A-Award | 194,000 | $10 |
| Mar 9, 2026 | Kelly James Patrick · officer: EVP, CFO and Treasurer | F-InKind | 5,904 | $9.98 |
| Mar 9, 2026 | Draghia-Akli Ruxandra · officer: EVP, Research & Development | A-Award | 139,500 | $10 |
| Mar 9, 2026 | O'Hara Elaine · officer: EVP, Chief Strategy Officer | A-Award | 177,500 | $10 |
Institutional positioning
13F filings over the trailing two quarters
New 98Increased 155Reduced 165Sold out 31
| Filer | Action | Shares | Filed |
|---|---|---|---|
| SHAH CAPITAL MANAGEMENT | Increased | 14,845,097 | Apr 24, 2026 |
| SHAH CAPITAL MANAGEMENT | Reduced | 14,165,577 | Aug 14, 2026 |
| BlackRock, Inc. | Increased | 13,946,881 | Aug 7, 2026 |
| BLACKROCK, INC. | Reduced | 12,844,319 | May 13, 2026 |
| STATE STREET CORP | Increased | 11,740,550 | Aug 7, 2026 |
| STATE STREET CORP | Reduced | 8,970,518 | May 15, 2026 |
| D. E. SHAW & CO., INC. | Increased | 8,094,658 | May 15, 2026 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | Increased | 7,607,996 | Aug 13, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | Increased | 7,257,449 | Aug 13, 2026 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | New Position | 7,151,625 | May 8, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 7,130,147 | May 15, 2026 |
| Sanofi | Unchanged | 6,880,481 | Jul 28, 2026 |
| SANOFI | Unchanged | 6,880,481 | May 7, 2026 |
| BANK OF AMERICA CORP /DE/ | Reduced | 6,637,213 | May 18, 2026 |
| D. E. Shaw & Co., Inc. | Reduced | 6,031,905 | Aug 14, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Jun 23, 2026